🇺🇸 FDA
Patent

US 11285153

Substituted pyrimidine piperazine compound and use thereof

granted A61KA61K31/506A61K45/06

Quick answer

US patent 11285153 (Substituted pyrimidine piperazine compound and use thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/506, A61K45/06, A61P, A61P15/08